Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
Mylan Discontinues Propoxyphene Hydrochloride 32 mg Oral Capsule (ANDA083528)
Mylan’s ANDA083528 for propoxyphene hydrochloride 32 mg oral capsules is listed as discontinued by the FDA.
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
Mylan's GLIMEPIRIDE ANDA077486 Receives FDA Approval
The FDA approved Mylan's ANDA077486 for GLIMEPIRIDE tablets (1mg, 2mg, 4mg), though all listed products are marked as discontinued.